Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
Appointed director
|
|
Cascadian Therapeutics, Inc. (CASC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/11/2019 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 05/22/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 04/09/2018 |
SC 13G/A
| Baupost Group reports a 0% stake in Cascadian Therapeutics, Inc. |
| 03/22/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/22/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/22/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/22/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/22/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/19/2018 |
SC 13D/A
| Growth Equity Opportunities IV, LLC has filed a Schedule 13D for Cascadian Therapeutics, Inc. |
| 03/13/2018 |
4
| Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,315 shares
@ $0
Disposed/sold 2,500 options to buy
@ $35.88, valued at
$89.7k
Disposed/sold 334 options to buy
@ $41.52, valued at
$13.9k
Disposed/sold 1,250 options to buy
@ $28.44, valued at
$35.6k
Disposed/sold 2,500 options to buy
@ $10.44, valued at
$26.1k
Disposed/sold 1,250 options to buy
@ $10.56, valued at
$13.2k
Disposed/sold 5,834 options to buy
@ $21.06, valued at
$122.9k
Disposed/sold 8,334 options to buy
@ $6.9, valued at
$57.5k
Disposed/sold 20,834 options to buy
@ $6.9, valued at
$143.8k
Disposed/sold 35,100 options to buy
@ $4.64, valued at
$162.9k
Disposed/sold 50,000 options to buy
@ $3.99, valued at
$199.5k
|
|
| 03/13/2018 |
4
| James Steven P (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 13,677 shares
@ $0
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| LOVE TED W (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 37,394 shares
@ $0
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,125 shares
@ $0
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| Sonsini Peter W. (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| Sakoda Jon (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| MOTT DAVID M (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| MAKOWER JOSHUA (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,639 shares
@ $0
Disposed/sold 8,334 options to buy
@ $19.92, valued at
$166k
Disposed/sold 8,334 options to buy
@ $41.52, valued at
$346k
Disposed/sold 8,334 options to buy
@ $28.44, valued at
$237k
Disposed/sold 25,000 options to buy
@ $10.44, valued at
$261k
Disposed/sold 25,000 options to buy
@ $10.56, valued at
$264k
Disposed/sold 41,667 options to buy
@ $21.06, valued at
$877.5k
Disposed/sold 54,167 options to buy
@ $6.9, valued at
$373.8k
Disposed/sold 51,200 options to buy
@ $4.64, valued at
$237.6k
Disposed/sold 65,000 options to buy
@ $3.99, valued at
$259.4k
Disposed/sold 11,300 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| Azelby Robert (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Disposed/sold 12,437 restricted stock units
@ $0
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 21,006 shares
@ $0
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| Myers Scott Dunseth (President and CEO) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 56,787 shares
@ $0
Disposed/sold 474,810 options to buy
@ $7.08, valued at
$3.4M
Disposed/sold 190,000 options to buy
@ $4.64, valued at
$881.6k
Disposed/sold 60,000 options to buy
@ $3.99, valued at
$239.4k
Disposed/sold 42,000 restricted stock units
@ $0
Disposed/sold 15,500 restricted stock units
@ $0
Disposed/sold 6,300 restricted stock units
@ $0
Disposed/sold 250,000 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| BARRIS PETER J (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| Growth Equity Opportunities IV, LLC (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/13/2018 |
4
| Christianson Gary (COO) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 6,515 shares
@ $0
Disposed/sold 8,334 options to buy
@ $19.92, valued at
$166k
Disposed/sold 8,334 options to buy
@ $41.52, valued at
$346k
Disposed/sold 8,334 options to buy
@ $28.44, valued at
$237k
Disposed/sold 25,000 options to buy
@ $10.44, valued at
$261k
Disposed/sold 16,667 options to buy
@ $10.56, valued at
$176k
Disposed/sold 41,667 options to buy
@ $21.06, valued at
$877.5k
Disposed/sold 41,667 options to buy
@ $6.9, valued at
$287.5k
Disposed/sold 51,200 options to buy
@ $4.64, valued at
$237.6k
Disposed/sold 68,000 options to buy
@ $3.99, valued at
$271.3k
Disposed/sold 11,300 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| HENNEY CHRISTOPHER S (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 60,185 shares
@ $0
Disposed/sold 25,000 options to buy
@ $6.36, valued at
$159k
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/13/2018 |
4
| EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 5,237 shares
@ $0
Disposed/sold 6,667 options to buy
@ $19.86, valued at
$132.4k
Disposed/sold 8,334 options to buy
@ $19.92, valued at
$166k
Disposed/sold 8,334 options to buy
@ $41.52, valued at
$346k
Disposed/sold 8,334 options to buy
@ $28.44, valued at
$237k
Disposed/sold 25,000 options to buy
@ $10.44, valued at
$261k
Disposed/sold 16,667 options to buy
@ $10.56, valued at
$176k
Disposed/sold 41,667 options to buy
@ $21.06, valued at
$877.5k
Disposed/sold 50,000 options to buy
@ $6.9, valued at
$345k
Disposed/sold 51,200 options to buy
@ $4.64, valued at
$237.6k
Disposed/sold 75,000 options to buy
@ $3.99, valued at
$299.3k
|
|
| 03/09/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 03/09/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/09/2018 |
POS462B
| Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]: |
| 03/09/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|
|
|